Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight ...

GSK Plc raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s last report as chief executive officer.

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GlaxoSmithKline (GSK) plc has announced the purchase of 167,000 of its own ordinary shares, ...

The drugmaker now expects 2025 sales growth between 6% to 7% when excluding currency movements, up from a 3% to 5% range.

GSK plc has announced provisional dividend dates for the year 2026, outlining key dates for ordinary shares and American Depositary Shares. These dates are subject to change and provide stakeholders ...

GSK presents data from its advancing liver pipeline at AASLD 2025: London, UK Monday, November 10, 2025, 11:00 Hrs [IST] GSK plc will showcase latest advances in its liver pipelin ...

GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two treatment combinations with the British firm's blood cancer drug, limiting the ...

GSK shares rose to the top of the FTSE 100 leader board after the drugmaker raised its 2025 guidance on the back of a strong third-quarter performance. The earnings were the last to be presented by ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the British drug giant feels prepared for any challenges that U.S. drug import ...

Data from a new GSK survey released today highlight a potential blind spot in Respiratory Syncytial Virus (RSV) awareness ...

GSK Pharma share price fell 3 per cent after it reported a lower-than-expected top-line for the second quarter of the current ...